Myriad Sues Third Firm, BioReference's GeneDx, Alleging BRCA1/2 Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics and other parties are suing BioReference Laboratories' GeneDx alleging infringement of patents covering BRCA1 and BRCA2 genes.

Along with Myriad, the University of Utah Research Foundation, the trustees of the University of Pennsylvania, Toronto's Hospital for Sick Children, and Endorecherche are plaintiffs in the lawsuit, which was filed last week in US District Court for the District of Utah, Central Division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.